[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100436469":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":13,"locations":19,"responsibleParty":35,"collaborators":37,"id":41,"slug":42,"hasResults":43,"nctId":44,"briefTitle":45,"officialTitle":45,"acronym":46,"eligibilityCriteria":47,"healthyVolunteers":43,"sex":48,"minAge":49,"maxAge":7,"enrollmentInfo":50,"targetDuration":7,"studyType":53,"phases":7,"briefSummary":54,"conditions":55,"keywords":57,"overallStatus":40,"whyStopped":7,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":72},{"fullName":5,"class":6},"Azienda Usl di Bologna","OTHER_GOV",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"DIAGNOSTIC_TEST","Adult subjects diagnosed with IS or TIA","From the moment the person decides to participate, the patient will undergo the first 24-hour cycle of monitoring with a high-resolution 12-lead Holter. The following day, the Holter report generated will be analyzed by an expert electrocardiographic. After the removal of the first Holter, the study subject will undergo a second monitoring with a 3-lead Holter device for a duration of 6 days, followed by decontamination of the device and archiving of data The electronic data relating to the monitoring periods with Holter will be analyzed with various high-sensitivity AF detection algorithms in order to identify the outcome of the study.",[14],{"name":15,"role":16,"phone":17,"phoneExt":7,"email":18},"Zini Andrea, Md","CONTACT","051 6478481","a.zini@ausl.bologna.it",[20],{"facility":21,"status":22,"city":23,"state":7,"zip":7,"country":24,"countryCode":25,"cosmosGeoPoint":26,"geoPoint":31,"contacts":32},"IRCCS Istituto delle Scienze Neurologiche di Bologna","RECRUITING","Bologna","Italy","IT",{"type":27,"coordinates":28},"Point",[29,30],11.33875,44.49381,{"lat":30,"lon":29},[33],{"name":34,"role":16,"phone":17,"phoneExt":7,"email":18},"Andrea Zini, MD",{"type":36,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR",[38],{"name":39,"class":40},"Mortara Instrument Europe S.r.l.","UNKNOWN","100436469","7-day-holter-monitoring-in-adult-patients-with-recent-is-or-tia-to-measure-the-prevalence-of-paroxysmal-atrial-fibrillation-including-episodes-less-than-30-seconds-transversal-study-100436469",false,"NCT04963647","7-day Holter Monitoring in Adult Patients With Recent IS or TIA, to Measure the Prevalence of Paroxysmal Atrial Fibrillation Including Episodes Less Than 30 Seconds: Transversal Study","MY-ATRIA","Inclusion Criteria:\n\nI. Patients admitted to the UOC of Neurology and Metropolitan Stroke Network diagnosed with IS or TIA. The diagnosis will be confirmed through standardized clinical practice which may include one or more of the following diagnostic tests:\n\n1. imaging tests such as computed tomography (CT),\n2. magnetic resonance imaging (MRI),\n3. computed tomographic angiography (ANGIOTC),\n4. magnetic resonance angiography (MRA),\n5. blood flow tests such as cerebral angiography or cerebral arteriography. II. Patients with IS or TIA within 7 days of the clinical episode. III. Obtaining informed consent (signed and dated). IV. Adult patients (over 18 years of age).\n\nExclusion Criteria:\n\nI. Patients with PM o ICD. II. Patients diagnosed with hemorrhagic stroke. III. Patients who have undergone cardiac surgery in the 30 days prior to enrollment.\n\nIV. More than 7 days between the IS or TIA episode and patient enrollment. V. Patient diagnosed with AF based on a resting ECG performed at the time of enrollment.\n\nVI. Patient with a previous diagnosis of permanent AF or persistent AF. VII. Patient previously enrolled in this clinical study. VIII. Pregnancy.","ALL","18 Years",{"count":51,"type":52},660,"ESTIMATED","OBSERVATIONAL","The main outcome of this study will be to compare the prevalence of PA AF episodes longer than 30 seconds versus the prevalence of PA AF episodes including episodes shorter than 30 seconds, in adult patients who survived IS or TIA with no previous history of AF, after 7-day Holter monitoring. Based on the previous assumptions, the secondary objectives of the project will be:\n\n1. To compare the prevalence of patients diagnosed with BAF after 24-hour, 72-hour, and 7-day Holter monitoring.\n2. To study the feasibility of using information obtained from the ECG during sinus rhythm, for example the characteristics of the P-wave, to predict the presence of PA AF and BAF.\n3. To Collect a new database of multi-monitored, high-resolution, long-term ECG signals. The data will be used by the My-Atria consortium for research purposes, for the development and validation of arrhythmia detection algorithms.\n\nThe results of the study are intended to have an impact on how AF is screened, diagnosed, and treated. The results will also contribute to the choice of the most appropriate secondary stroke prevention modality, which therefore refers to the treatment of subjects who have already had an episode of IS or TIA.",[56],"Atrial Fibrillation",[58,59,56,60,61,62],"7 day holter monitoring","tia","IS","stroke","Brief atrial fibrillation","2021-07-06",{"date":65,"type":66},"2021-07-15","ACTUAL",{"date":68,"type":66},"2021-06-16",{"date":70,"type":52},"2023-06-16",{"name":5,"class":6},1]